These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 10952323)

  • 21. Clinical and biomaterial evaluation of hyaluronan-based heparin-bonded extracorporeal circuits with reduced versus full systemic anticoagulation in reoperation for coronary revascularization.
    Gunaydin S; Farsak B; McCusker K; Vijay V; Sari T; Onur MA; Gurpinar A; Zorlutuna Y
    J Cardiovasc Med (Hagerstown); 2009 Feb; 10(2):135-42. PubMed ID: 19377380
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improving cardiopulmonary bypass: heparin-coated circuits.
    Vocelka C; Lindley G
    J Extra Corpor Technol; 2003 Dec; 35(4):312-6. PubMed ID: 14979422
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Coronary artery bypass surgery with heparin-coated perfusion circuits and low-dose heparinization.
    Mullen JC; Bentley MJ; Gelfand ET; Koshal A; Modry DL; Guenther CR; Etches WS; Stang LJ; Lopushinsky SR
    Can J Surg; 2002 Jun; 45(3):166-72. PubMed ID: 12067167
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical performance and biocompatibility of hyaluronan-based heparin-bonded extracorporeal circuits in different risk cohorts.
    Gunaydin S; McCusker K; Sari T; Onur MA; Zorlutuna Y
    Interact Cardiovasc Thorac Surg; 2010 Mar; 10(3):371-6. PubMed ID: 20026488
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Centrifugal pump and heparin coating improves cardiopulmonary bypass biocompatibility.
    Moen O; Fosse E; Dregelid E; Brockmeier V; Andersson C; Høgåsen K; Venge P; Mollnes TE; Kierulf P
    Ann Thorac Surg; 1996 Oct; 62(4):1134-40. PubMed ID: 8823102
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Heparin-coated cardiopulmonary bypass circuits and 25% reduction of heparin dose in coronary artery surgery--a clinical study.
    Borowiec J; Thelin S; Bagge L; van der Linden J; Thörnö E; Hansson HE
    Ups J Med Sci; 1992; 97(1):55-66. PubMed ID: 1523735
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical study of biocompatibility between open and closed heparin-coated cardiopulmonary bypass circuits.
    Tanaka H; Oshiyama T; Narisawa T; Mori T; Masuda M; Kishi D; Kitou T; Miyazima S
    J Artif Organs; 2003; 6(4):245-52. PubMed ID: 14691666
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effects of heparin coated circuits on pulmonary injury. A clinical study.
    Kazaz H; Oto O; Sariosmanoglu N; Hazan E
    J Cardiovasc Surg (Torino); 2003 Oct; 44(5):611-5. PubMed ID: 14735048
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Heparin-coated cardiopulmonary bypass circuits: current status.
    Hsu LC
    Perfusion; 2001 Sep; 16(5):417-28. PubMed ID: 11565897
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of cardiopulmonary bypass on blood cell filterability in children undergoing cardiac surgery.
    Bergman P; Belboul A; Friberg LG; Mellgren G; Roberts D
    J Cardiovasc Surg (Torino); 1998 Apr; 39(2):181-91. PubMed ID: 9639003
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Heparin-coated circuits reduce occult myocardial damage during CPB: a randomized, single blind clinical trial.
    Belboul A; Löfgren C; Storm C; Jungbeck M
    Eur J Cardiothorac Surg; 2000 May; 17(5):580-6. PubMed ID: 10814923
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Closed cardiopulmonary bypass circuits suppress thrombin generation during coronary artery bypass grafting.
    Nakahira A; Sasaki Y; Hirai H; Fukui T; Matsuo M; Takahashi Y; Kotani S; Suehiro S
    Interact Cardiovasc Thorac Surg; 2010 Apr; 10(4):555-60. PubMed ID: 20061337
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Trillium coating of cardiopulmonary bypass circuits improves biocompatibility.
    Tevaearai HT; Mueller XM; Seigneul I; Burki M; Horisberger J; Stumpe F; Von Segesser LK
    Int J Artif Organs; 1999 Sep; 22(9):629-34. PubMed ID: 10532432
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Does heparin coating improve biocompatibility? A study on complement, blood cells and postoperative morbidity during cardiac surgery.
    Belboul A; al-Khaja N
    Perfusion; 1997 Nov; 12(6):385-91. PubMed ID: 9413851
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantitative evaluation of heparin-coated versus non-heparin-coated bypass circuits during cardiopulmonary bypass.
    Stammers AH; Christensen KA; Lynch J; Zavadil DP; Deptula JJ; Sydzyik RT
    J Extra Corpor Technol; 1999 Sep; 31(3):135-41. PubMed ID: 10847956
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The impact of heparin-coated circuits on hemodynamics during and after cardiopulmonary bypass.
    de Vroege R; Huybregts R; van Oeveren W; van Klarenbosch J; Linley G; Mutlu J; Jansen E; Hack E; Eijsman L; Wildevuur C
    Artif Organs; 2005 Jun; 29(6):490-7. PubMed ID: 15926987
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inflammatory response after coronary revascularization: off-pump versus on-pump (heparin-coated circuits and poly2methoxyethylacrylate-coated circuits).
    Hazama S; Eishi K; Yamachika S; Noguchi M; Ariyoshi T; Takai H; Odate T; Matsukuma S; Onohara D; Yanatori M
    Ann Thorac Cardiovasc Surg; 2004 Apr; 10(2):90-6. PubMed ID: 15209550
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transfusion after coronary artery bypass surgery: the impact of heparin-bonded circuits.
    Mahoney CB; Lemole GM
    Eur J Cardiothorac Surg; 1999 Aug; 16(2):206-10. PubMed ID: 10485422
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diffusion-weighted magnetic resonance imaging for the detection of ischemic brain lesions in coronary artery bypass graft surgery: relation to extracorporeal circulation and heparinization.
    Mirow N; Zittermann A; Körperich H; Börgermann J; Koertke H; Knobl H; Gieseke J; Ostertun B; Coskun T; Kleesiek K; Burchert W; Gummert JF
    J Cardiovasc Surg (Torino); 2011 Feb; 52(1):117-26. PubMed ID: 21224820
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reducing the post-pump syndrome by using heparin-coated circuits, steroids, or aprotinin.
    Harig F; Feyrer R; Mahmoud FO; Blum U; von der Emde J
    Thorac Cardiovasc Surg; 1999 Apr; 47(2):111-8. PubMed ID: 10363611
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.